Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
Autor: | E. C. van Hove, Marlous J. Groenewoud, E. van 't Riet, Johannes A Maassen, L.M.C. Welschen, Erwin Reiling, Leen M 't Hart, J. M. Dekker, Giel Nijpels |
---|---|
Přispěvatelé: | General practice, Internal medicine, Epidemiology and Data Science, EMGO - Lifestyle, overweight and diabetes |
Rok vydání: | 2009 |
Předmět: |
Blood Glucose
Male medicine.medical_specialty endocrine system diseases G6PC2 Endocrinology Diabetes and Metabolism Single-nucleotide polymorphism Type 2 diabetes Polymorphism Single Nucleotide Article Cohort Studies Reference Values Risk Factors Diabetes mellitus Internal medicine Glucokinase Glucose Intolerance Internal Medicine medicine Genetics Humans Genetic Predisposition to Disease Melatonin Receptor Type 1B Adaptor Proteins Signal Transducing Glucokinase regulatory protein biology Receptor Melatonin MT2 Fasting plasma glucose Fasting Middle Aged medicine.disease Endocrinology Diabetes Mellitus Type 2 biology.protein Glucose-6-Phosphatase Female Glucose 6-phosphatase |
Zdroj: | Diabetologia, 52(9), 1866-1870. Springer Verlag Diabetologia Reiling, E, van 't Riet, E, Groenewoud, M J, Welschen, L M C, van Hove, E C, Nijpels, M G A A M, Maassen, J A, Dekker, J M & Hart, L M 2009, ' Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk ', Diabetologia, vol. 52, no. 9, pp. 1866-1870 . https://doi.org/10.1007/s00125-009-1413-9 |
ISSN: | 0012-186X |
DOI: | 10.1007/s00125-009-1413-9 |
Popis: | Aims/hypothesis Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2) and melatonin receptor type 1B (MTNR1B) is associated with FPG. In this study we examined whether these loci also contribute to type 2 diabetes susceptibility. Methods A random selection from the Dutch New Hoorn Study was used for replication of the association with FGP (2,361 non-diabetic participants). For the genetic association study we extended the study sample with 2,628 participants with type 2 diabetes. Risk allele counting was used to calculate a four-gene risk allele score for each individual. Results Variants of the GCK, G6PC2 and MTNR1B genes but not GCKR were associated with FPG (all, p ≤ 0.001; GCKR, p = 0.23). Combining these four genes in a risk allele score resulted in an increase of 0.05 mmol/l (0.04–0.07) per additional risk allele (p = 2 × 10−13). Furthermore, participants with less than three or more than five risk alleles showed significantly different type 2 diabetes susceptibility compared with the most common group with four risk alleles (OR 0.77 [0.65–0.93], p = 0.005 and OR 2.05 [1.50–2.80], p = 4 × 10−6 respectively). The age at diagnosis was also significantly associated with the number of risk alleles (p = 0.009). Conclusions A combined risk allele score for single-nucleotide polymorphisms in four known FPG loci is significantly associated with FPG and HbA1c in a Dutch population-based sample of non-diabetic participants. Carriers of low or high numbers of risk alleles show significantly different risks for type 2 diabetes compared with the reference group. Electronic supplementary material The online version of this article (doi:10.1007/s00125-009-1413-9) contains supplementary material, which is available to authorised users. |
Databáze: | OpenAIRE |
Externí odkaz: |